Basel Medical Group Ltd Ordinary Shares (BMGL) — Long-term Investment Intensity
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Long-term Investment Intensity of 0.0% as of June 2025. Long-term investments of $49.00 represent 0.0% of total assets of $16.85 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BMGL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Basel Medical Group Ltd Ordinary Shares Long-term Investment Intensity (2025–2025)
This chart shows how Basel Medical Group Ltd Ordinary Shares's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2025, the intensity stands at 0.0%, reflecting long-term investments of $49.00 against total assets of $16.85 Million USD. Explore BMGL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Basel Medical Group Ltd Ordinary Shares (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Basel Medical Group Ltd Ordinary Shares from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BMGL stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.0% | $49.00 | $16.85 Million | — |